teaser
Shire plc, theglobal specialty biopharmaceutical company, is committed to doingeverything possible to assist Gaucher patients and their physiciansduring the imiglucerase supply shortage. Shire is pleased to be able toprovide velaglucerase alfa well over a year ahead of previouslyanticipated commercial launch world wide.